Cargando…
CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
Ovarian cancer (OC) is a type of gynaecological malignancy with high mortality in females. Serous ovarian cancer (SOC) is a distinct subtype of OC with poor early diagnosis. Given the limitations of traditional therapies, such as chemotherapy, targeted treatment is therefore a promising therapy to i...
Autores principales: | Qi, Zhi-Ying, Wang, Fang, Yue, Ying-Ying, Guo, Xue-Wang, Guo, Rui-Meng, Li, Hong-Lin, Xu, Yan-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884760/ https://www.ncbi.nlm.nih.gov/pubmed/31783885 http://dx.doi.org/10.1186/s13048-019-0593-2 |
Ejemplares similares
-
Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
por: Qi, Zhi-Ying, et al.
Publicado: (2023) -
SOCS7/HuR/FOXM1 signaling axis inhibited high-grade serous ovarian carcinoma progression
por: Du, Yanhua, et al.
Publicado: (2022) -
Role of CyPA in cardiac hypertrophy and remodeling
por: Cao, Mengfei, et al.
Publicado: (2019) -
The Development and Validation of a CT-Based Radiomics Nomogram to Preoperatively Predict Lymph Node Metastasis in High-Grade Serous Ovarian Cancer
por: Chen, Hui-zhu, et al.
Publicado: (2021) -
Structural and biochemical insights of CypA and AIF interaction
por: Farina, Biancamaria, et al.
Publicado: (2017)